EP0675723A4 - Bisphosphonate/estrogen therapy for treating and preventing bone loss. - Google Patents
Bisphosphonate/estrogen therapy for treating and preventing bone loss.Info
- Publication number
- EP0675723A4 EP0675723A4 EP94905419A EP94905419A EP0675723A4 EP 0675723 A4 EP0675723 A4 EP 0675723A4 EP 94905419 A EP94905419 A EP 94905419A EP 94905419 A EP94905419 A EP 94905419A EP 0675723 A4 EP0675723 A4 EP 0675723A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- bisphosphonate
- treating
- bone loss
- preventing bone
- estrogen therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99641892A | 1992-12-23 | 1992-12-23 | |
US996418 | 1992-12-23 | ||
PCT/US1993/012302 WO1994014455A1 (en) | 1992-12-23 | 1993-12-17 | Bisphosphonate/estrogen therapy for treating and preventing bone loss |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0675723A1 EP0675723A1 (en) | 1995-10-11 |
EP0675723A4 true EP0675723A4 (en) | 1998-08-05 |
Family
ID=25542895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP94905419A Ceased EP0675723A4 (en) | 1992-12-23 | 1993-12-17 | Bisphosphonate/estrogen therapy for treating and preventing bone loss. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0675723A4 (en) |
JP (1) | JPH08505142A (en) |
AU (1) | AU5953894A (en) |
CA (1) | CA2151240A1 (en) |
WO (1) | WO1994014455A1 (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2065313T5 (en) * | 1993-05-15 | 2004-01-01 | Roche Diagnostics Gmbh | TABLET WITH IMPROVED BIODISPONIBILITY CONTAINING DICHLOROMETILENDIFOSFONICO ACID AS ACTIVE SUBSTANCE. |
US5646134A (en) * | 1994-04-21 | 1997-07-08 | Merck & Co., Inc. | Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices |
UA41909C2 (en) * | 1994-07-22 | 2001-10-15 | Елі Ліллі Енд Компані | Use A combination of compounds for the inhibition of osteoporosis, a pharmaceutical agent |
US5780455A (en) * | 1994-08-24 | 1998-07-14 | Merck & Co., Inc. | Intravenous alendronate formulations |
EP0824341A4 (en) * | 1995-05-12 | 1999-07-07 | Merck & Co Inc | Prevention of tooth loss by the administration of alendronate or its salts |
US5545635A (en) * | 1995-05-23 | 1996-08-13 | Eli Lilly And Company | Inhibiting bone loss with equilenin |
US5616571A (en) * | 1995-06-06 | 1997-04-01 | Merck & Co., Inc. | Bisphosphonates prevent bone loss associated with immunosuppressive therapy |
IL120265A0 (en) * | 1996-02-28 | 1997-06-10 | Pfizer | Combination therapy to treat osteoporosis - polyphosphonates or progestins and estrogen agonists |
IL120270A0 (en) * | 1996-02-28 | 1997-06-10 | Pfizer | Combination therapy to treat osteoporosis |
AU712710B2 (en) * | 1996-05-17 | 1999-11-11 | Merck Sharp & Dohme Corp. | Effervescent bisphosphonate formulation |
EP1378234A1 (en) * | 1996-05-17 | 2004-01-07 | MERCK & CO. INC. | Effervescent bisphosphonate formulation |
US5853759A (en) * | 1996-05-17 | 1998-12-29 | Merck & Co.. Inc. | Effervescent alendronate formulation |
JP2001507338A (en) * | 1996-11-25 | 2001-06-05 | メルク エンド カンパニー インコーポレーテッド | Androgenic and bisphosphonic acid co-administered to treat disease |
US6376477B2 (en) | 1996-11-25 | 2002-04-23 | Merck & Co., Inc. | Combination of an agent that binds to the androgen receptor and a bisphosphonic acid in the prevention and/or treatment of diseases involving calcium or phosphate metabolism |
DE19719680A1 (en) | 1997-05-09 | 1998-11-19 | Boehringer Mannheim Gmbh | Use of diphosphonic acids for the preventive treatment of long-term consequences of bladder enlargement or replacement |
US6555529B1 (en) * | 1997-12-25 | 2003-04-29 | Toray Industries, Inc. | Remedies for intramedullary diseases |
PT1135140E (en) * | 1998-12-04 | 2005-10-31 | Roche Diagnostics Gmbh | UTILIZATION OF IBANDRONATO FOR THE PROMOTION OF ENDOPROTESES OSSEA INTEGRATION |
EP1210138A4 (en) * | 1999-04-22 | 2003-05-07 | Hydro Med Sciences Inc | Controlled delivery of bisphosphonates |
AUPQ232599A0 (en) * | 1999-08-19 | 1999-09-09 | Royal Alexandra Hospital For Children, The | Drug for treating fractures |
FR2803521B1 (en) * | 2000-01-12 | 2002-10-25 | Ceva Sante Animale | USE OF TILUDRONIC ACID AND ITS DERIVATIVES IN POULTRY FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR PREVENTING AND TREATING OSTEOPOROSIS |
US7425549B2 (en) * | 2001-02-06 | 2008-09-16 | The Royal Alexandra Hospital For Children | Drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis |
WO2002080933A1 (en) * | 2001-04-03 | 2002-10-17 | The Royal Alexandra Hospital For Children | A drug for use in bone grafting |
AUPR553701A0 (en) * | 2001-06-07 | 2001-07-12 | Royal Alexandra Hospital For Children, The | A device for the delivery of a drug to a fractured bone |
TWI315982B (en) | 2001-07-19 | 2009-10-21 | Novartis Ag | Combinations comprising epothilones and pharmaceutical uses thereof |
WO2003057136A2 (en) | 2001-12-24 | 2003-07-17 | Teva Pharmaceutical Industries Ltd. | Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it |
US7488496B2 (en) | 2002-03-06 | 2009-02-10 | Christer Rosen | Effervescent compositions comprising bisphosphonates and methods related thereto |
EP1508343B1 (en) * | 2003-08-21 | 2015-11-04 | AddBIO AB | Bisphosponate coated implant device and method therefor |
US8940320B2 (en) | 2005-10-27 | 2015-01-27 | Thommen Medical Ag | Dental implant and production method for said implant |
US8882740B2 (en) | 2009-12-23 | 2014-11-11 | Stryker Trauma Gmbh | Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992005187A1 (en) * | 1990-09-18 | 1992-04-02 | Boehringer Mannheim Gmbh | NEW 17-β-OESTRADIOL DERIVATIVES, A METHOD OF PREPARING THEM, AND DRUGS CONTAINING THEM |
EP0496520A1 (en) * | 1991-01-22 | 1992-07-29 | Merck & Co. Inc. | Novel bone acting agents |
WO1992014474A1 (en) * | 1991-02-26 | 1992-09-03 | Norwich Eaton Pharmaceuticals, Inc. | Methods for the treatment of osteoporosis |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3623397A1 (en) * | 1986-07-11 | 1988-01-14 | Boehringer Mannheim Gmbh | NEW DIPHOSPHONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
-
1993
- 1993-12-17 CA CA002151240A patent/CA2151240A1/en not_active Abandoned
- 1993-12-17 AU AU59538/94A patent/AU5953894A/en not_active Abandoned
- 1993-12-17 EP EP94905419A patent/EP0675723A4/en not_active Ceased
- 1993-12-17 WO PCT/US1993/012302 patent/WO1994014455A1/en not_active Application Discontinuation
- 1993-12-17 JP JP6515312A patent/JPH08505142A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992005187A1 (en) * | 1990-09-18 | 1992-04-02 | Boehringer Mannheim Gmbh | NEW 17-β-OESTRADIOL DERIVATIVES, A METHOD OF PREPARING THEM, AND DRUGS CONTAINING THEM |
EP0496520A1 (en) * | 1991-01-22 | 1992-07-29 | Merck & Co. Inc. | Novel bone acting agents |
WO1992014474A1 (en) * | 1991-02-26 | 1992-09-03 | Norwich Eaton Pharmaceuticals, Inc. | Methods for the treatment of osteoporosis |
Non-Patent Citations (2)
Title |
---|
CIMINERA N. ET AL: "Studio Comparativo degli effeti di estrogeni e difosfonati sulla perdita ossea postmenopausale", ANN. OSTET. GINECOL. MED. PERINAT., vol. 113, no. 5, 1992, pages 232 - 237, XP002064831 * |
See also references of WO9414455A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2151240A1 (en) | 1994-07-07 |
WO1994014455A1 (en) | 1994-07-07 |
EP0675723A1 (en) | 1995-10-11 |
JPH08505142A (en) | 1996-06-04 |
AU5953894A (en) | 1994-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0675723A4 (en) | Bisphosphonate/estrogen therapy for treating and preventing bone loss. | |
GB9411080D0 (en) | Treatment | |
ZA95556B (en) | Combination treatment for osteoporosis | |
AP9300539A0 (en) | Steroidal glycosides for treating hypercholest erolemia | |
IL115310A0 (en) | Combination therapy for hypercholesterolemia | |
EP0589252A3 (en) | Fibrillation induction method for implantable devices. | |
AP2002002661A0 (en) | Combination therapy for oesteoporosis | |
ZA958688B (en) | Methods for treating resistant tumors | |
IL122149A0 (en) | Bisphosphonates preventing bone loss associated with immunosuppressive therapy | |
GB2296108B (en) | Tractor and machine combination and control system therefor | |
GB9808936D0 (en) | Combination therapy for the prevention and treatment of osteoporosis | |
GB9303210D0 (en) | Cancer treatment | |
GB9215042D0 (en) | Microwave treatment apparatus | |
HU9302183D0 (en) | Medical preparatives for preventing and treating osteoporises after menopausa | |
IL108197A0 (en) | Pharmaceutical composition for preventing or treating arterioscleriosis | |
EP0650372A4 (en) | Compounds for cancer imaging and therapy. | |
HU9402578D0 (en) | Medicament for treating or preventing cerebrovascular diseases | |
GB9308802D0 (en) | Treatment | |
GB9315275D0 (en) | Formulation for treating silage | |
EP0839032A4 (en) | Hydroxyl ions as unique therapeutic agents and compounds that modulate ions, compounds | |
PL320564A1 (en) | Therapeutic set for treating osteoporosis | |
PL331283A1 (en) | Preparation for treating and/or preventing stupefaction | |
HK1021946A1 (en) | Electromagnetic therapeutic treatment device. | |
GB9201630D0 (en) | Off-gas treatment | |
EP0662782A4 (en) | Pp14-based therapy. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19950724 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19980619 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE |
|
17Q | First examination report despatched |
Effective date: 19981008 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20031106 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1009249 Country of ref document: HK |